Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131714) titled 'A Prospective Clinical Study of a Thiotepa-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia' on Sept. 6.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Tianjin First Central Hospital
Condition:
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) for relapsed or refractory acute leukemia
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-21
Target Sample Size: Experimental group:30;
Countries of Recruitment:
China
To know more, visit https:...